References
Wellbeing and quality of life of family caregivers: influence of sleep quality
End-stage renal disease (ESRD) is a health problem encountered worldwide, and, according to the international registries, the number of patients with ESRD is increasing globally (Belasco et al, 2006). In Europe, some 564 638 people received renal replacement therapy in 2016, with about 84% of these receiving haemodialysis (HD), 12% receiving peritoneal dialysis and 4% receiving renal transplant (Kramer et al, 2019). In the UK, 7759 persons started renal replacement therapy in 2016, and the prevalence of this therapy increased from 523 per million population in 2000 to 962 per million in 2016 (Byrne et al, 2018). For instance, there was a 14% increase in the number of patients starting renal replacement therapy in 2016 compared with the number of those who had started therapy in 2011 (Byrne et al, 2018). In Jordan, there were approximately 5000 patients with ESRD receiving either HD or peritoneal dialysis by the end of 2015, with a prevalence rate of 709 per million population and an incidence of 800 new cases each year (As-Sayaideh et al, 2013). Despite many significant advances in medical treatment, ESRD remains a serious illness and one of the main causes of morbidity and mortality in Jordan (As-Sayaideh et al, 2013).
Register now to continue reading
Thank you for visiting Community Nursing and reading some of our peer-reviewed resources for district and community nurses. To read more, please register today. You’ll enjoy the following great benefits:
What's included
-
Limited access to clinical or professional articles
-
New content and clinical newsletter updates each month